{"id":62990,"date":"2025-12-30T18:33:18","date_gmt":"2025-12-30T13:03:18","guid":{"rendered":"https:\/\/www.nextias.com\/ca\/?p=62990"},"modified":"2025-12-30T18:34:25","modified_gmt":"2025-12-30T13:04:25","slug":"rabies-vaccine-concerns-india","status":"publish","type":"post","link":"https:\/\/www.nextias.com\/ca\/current-affairs\/30-12-2025\/rabies-vaccine-concerns-india","title":{"rendered":"Countries Raise Concern About \u2018Fake Rabies Vaccine\u2019 in India"},"content":{"rendered":"\n<p><strong>Syllabus: GS2\/Issues Related Health; GS4\/Ethics<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Context<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Recently countries like the UK, US, and Australia have issued an advisory about the counterfeit batch of Abhayrab, a rabies vaccine manufactured by government-owned Indian Immunologicals Limited (IIL).\u00a0<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About Abhayrab Counterfeit Controversy<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Abhayrab is a cell\u2011culture rabies vaccine <\/strong>manufactured by Indian Immunologicals Limited (IIL), in use since 2000 in India and over 40 countries.<\/li>\n\n\n\n<li>It reportedly<strong> holds around 40% of India\u2019s human rabies vaccine market<\/strong> and is widely used in government programmes, private hospitals, and for travellers.<\/li>\n\n\n\n<li>Indian Immunologicals Limited (IIL) stated that in January 2025, it detected one counterfeit batch with altered packaging.<\/li>\n\n\n\n<li>Later, the company stated that the <strong>batch was identified internally<\/strong>, following which regulatory and enforcement agencies were informed, and that the <strong>product was no longer available for sale.<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Understanding Rabies and Its Risks<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Rabies is a <strong>viral infection<\/strong> transmitted through the <strong>saliva of infected animals<\/strong> such as <strong>dogs, cats, bats, and monkeys.<\/strong>\u00a0<\/li>\n\n\n\n<li>It typically spreads through <strong>bites, scratches, or saliva entering open wounds<\/strong>.<\/li>\n\n\n\n<li>Symptoms may include Fever, headache, and nausea; hallucinations and fear of water (hydrophobia);<\/li>\n\n\n\n<li><strong>Post-exposure vaccination<\/strong>, given promptly after a potential exposure, is the <strong>most reliable way<\/strong> to prevent infection.<\/li>\n\n\n\n<li>According to <strong>India\u2019s National Rabies Control Program<\/strong>, 6,644 suspected human rabies cases and deaths were reported between 2012 and 2022.\n<ul class=\"wp-block-list\">\n<li>However, the <strong>WHO<\/strong> estimates a far higher toll, at around <strong>18,000\u201320,000 deaths annually<\/strong>, with up to <strong>two-thirds of victims under age 15<\/strong>.\n<ul class=\"wp-block-list\">\n<li>India alone accounts for <strong>36% of global rabies deaths<\/strong>.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li>The issue of rabies is particularly serious because <strong>it is almost 100% fatal once symptoms appear<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Ethical Perspectives of Abhayrab Controversy<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Public Health Ethics: <\/strong>The fake vaccine is a <strong>violation of the principle of non-maleficence<\/strong><strong><em>(\u2018do no harm\u2019) <\/em><\/strong>from a <strong>public health standpoint.<\/strong>\n<ul class=\"wp-block-list\">\n<li>Public health systems have an ethical duty to <strong>ensure the safety, efficacy, and authenticity<\/strong> of all vaccines.<\/li>\n\n\n\n<li>Distributing fake vaccines <strong>breaches public trust<\/strong> and undermines future vaccination drives.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Professional Ethics in Medicine: <\/strong>Medical professionals who administered vaccines <strong>without verifying authenticity<\/strong> acted under <strong>compromised ethical conditions<\/strong>.\n<ul class=\"wp-block-list\">\n<li>However, many doctors were <strong>victims themselves<\/strong>, relying on state-supplied vaccines, <strong>a failure of institutional ethics<\/strong>, not individual negligence.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Corporate and Manufacturing Ethics: Pharmaceutical suppliers and intermediaries<\/strong> falsified batch numbers and expiry dates, violating <strong>business ethics<\/strong> and <strong>legal obligations<\/strong> under the <strong>Drugs and Cosmetics Act, 1940<\/strong>.\n<ul class=\"wp-block-list\">\n<li>Ethically, it is an act of <strong>deliberate deception<\/strong> risking lives for profit.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Regulatory Ethics: <\/strong>The <strong>Central Drugs Standard Control Organization (CDSCO)<\/strong> and <strong>state drug regulators<\/strong> failed to exercise <strong>due diligence<\/strong>.\n<ul class=\"wp-block-list\">\n<li>It exposes a <strong>moral lapse in oversight<\/strong>, echoing <strong><em>ethical negligence<\/em><\/strong> <strong>in governance<\/strong>, comparable to the Ranbaxy data falsification case (2013).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-background has-fixed-layout\" style=\"background-color:#fff2cc\"><tbody><tr><td><strong>Ethical Framework<\/strong><\/td><td><strong>Application to Fake Vaccine Case<\/strong><\/td><td><strong>Core Ethical Failure<\/strong><\/td><\/tr><tr><td><strong>Utilitarianism<\/strong><\/td><td>The harm (deaths, mistrust) outweighs any economic gain.<\/td><td>Violation of collective welfare.<\/td><\/tr><tr><td><strong>Deontological Ethics<\/strong><\/td><td>Authorities had a duty to ensure authenticity; failure to act violates duty-based ethics.<\/td><td>Breach of moral duty.<\/td><\/tr><tr><td><strong>Virtue Ethics<\/strong><\/td><td>Lack of integrity and accountability among suppliers\/regulators.<\/td><td>Absence of moral character.<\/td><\/tr><tr><td><strong>Justice Theory (Rawls)<\/strong><\/td><td>Unequal burden on rural poor violates fairness.<\/td><td>Distributive injustice.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Broader Implications<\/strong><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Trust Erosion:<\/strong> Communities may resist future vaccination campaigns (e.g., rabies, polio, COVID-19 boosters).<\/li>\n\n\n\n<li><strong>Systemic Reform Need:<\/strong> Experts from <strong>AIIMS and ICMR<\/strong> have called for <em>blockchain-based traceability<\/em> and <em>third-party audits<\/em> for all vaccine batches.<\/li>\n\n\n\n<li><strong>Moral Responsibility:<\/strong> Ethical accountability must extend beyond punishment to <strong>institutional reform<\/strong> and <strong>restoration of public trust<\/strong>.<\/li>\n<\/ul>\n\n\n\n<p><a href=\"https:\/\/indianexpress.com\/article\/explained\/explained-health\/countries-concern-about-fake-rabies-vaccine-case-10443477\/\" target=\"_blank\" rel=\"noopener\">Source: IE<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>Context<\/strong><\/p>\n<li class=\"ms-5\">Recently countries like the UK, US, and Australia have issued an advisory about the counterfeit batch of Abhayrab, a rabies vaccine manufactured by government-owned Indian Immunologicals Limited (IIL).\u00a0<\/li>\n<p><\/p>\n<p><strong> About Abhayrab Counterfeit Controversy <\/strong><\/p>\n<li class=\"ms-5\">Abhayrab is a cell\u2011culture rabies vaccine manufactured by Indian Immunologicals Limited (IIL), in use since 2000 in India and over 40 countries.<\/li>\n<li class=\"ms-5\">It reportedly holds around 40% of India\u2019s human rabies vaccine market and is widely used in government programmes, private hospitals, and for travellers.<\/li>\n<li class=\"ms-5\">Indian Immunologicals Limited (IIL) stated that in January 2025, it detected one counterfeit batch with altered packaging. <\/li>\n<p><a href=\"https:\/\/www.nextias.com\/ca\/current-affairs\/30-12-2025\/rabies-vaccine-concerns-india\" class=\"btn btn-primary btn-sm float-end\">Read\u00a0More<\/a><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-62990","post","type-post","status-publish","format-standard","hentry","category-current-affairs"],"acf":[],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/62990","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/comments?post=62990"}],"version-history":[{"count":2,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/62990\/revisions"}],"predecessor-version":[{"id":62993,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/posts\/62990\/revisions\/62993"}],"wp:attachment":[{"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/media?parent=62990"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/categories?post=62990"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nextias.com\/ca\/wp-json\/wp\/v2\/tags?post=62990"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}